β-ラクタム系抗生物質用酵素の世界市場レポート2026-2032

QY Research > レポート一覧 > 薬品及びサプリメント > β-ラクタム系抗生物質用酵素の世界市場レポート2026-2032

英文タイトル： Global Enzymes for β-lactam Antibiotics Market Research Report 2026

レポートID：1629777
発表時期：2026-07-09
訪問回数：425
ページ数：131
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：128
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

世界のβ-ラクタム系抗生物質用酵素市場は、2025年に160百万米ドルと算定されており、2026年には173百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）5.9%で推移し、2032年には244百万米ドルに達すると予測されています。

本レポートは、β-ラクタム系抗生物質用酵素メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界のβ-ラクタム系抗生物質用酵素市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、β-ラクタム系抗生物質用酵素に関する情報に基づいたビジネス判断を行うことを支援します。β-ラクタム系抗生物質用酵素市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Novozymes / Novonesis
DSM / dsm-firmenich
Amano Enzyme
Fermenta Biotech
Advanced Enzyme Technologies
Biosynth
Creative Enzymes
Codexis
c-LEcta / Kerry
Meiji Seika Pharma
Kyowa Hakko Bio
Datong Shuangyan Pharmaceutical
Shanghai Enzyme
Hubei Merriclin Pharmaceutical
Zhejiang Huahai Pharmaceutical
North China Pharmaceutical
CSPC Pharmaceutical Group

タイプ別
β-lactamase
Penicillin Acylase
Other

用途別
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other

製品カテゴリー

市場セグメント
Free Enzyme Type
Immobilized Enzyme Type
Recombinant Enzyme Type
Whole-Cell Catalyst Type

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界のβ-ラクタム系抗生物質用酵素市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：β-ラクタム系抗生物質用酵素の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：β-ラクタム系抗生物質用酵素メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：β-ラクタム系抗生物質用酵素の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでのβ-ラクタム系抗生物質用酵素の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：β-ラクタム系抗生物質用酵素に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別にβ-ラクタム系抗生物質用酵素の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：β-ラクタム系抗生物質用酵素の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：β-ラクタム系抗生物質用酵素の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：β-ラクタム系抗生物質用酵素市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

Description

The global Enzymes for β-lactam Antibiotics market was valued at US$ 160 million in 2025 and is anticipated to reach US$ 244 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Enzymes for β-lactam Antibiotics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Enzymes for β-lactam Antibiotics refer to industrial biocatalysts used in the production, transformation, side-chain modification, and intermediate preparation of β-lactam antibiotics, including penicillins, cephalosporins, carbapenems, and related semi-synthetic antibiotics. These enzymes are mainly used to selectively cleave or form side-chain amide bonds while preserving the β-lactam nucleus, enabling cleaner and milder manufacturing routes compared with traditional chemical processes. In this report, the market mainly includes penicillin G acylase, penicillin V acylase, cephalosporin C acylase, glutaryl acylase, D-amino acid oxidase, esterases, lipases, immobilized β-lactam acylases, recombinant enzyme catalysts, and engineered enzyme systems for β-lactam antibiotic synthesis. The 2025 benchmark ASP is US$68,000 / ton, shipment volume is 2.35k tons, and average gross margin is 48%. The upstream industry chain includes microbial strains, recombinant expression systems, fermentation media, enzyme carriers, immobilization resins, crosslinking reagents, buffers, filtration membranes, chromatography materials, and bioprocess equipment. The midstream includes strain engineering, enzyme fermentation, cell disruption, enzyme purification, immobilization, activity standardization, stability improvement, enzyme formulation, quality testing, packaging, and technical application support. The downstream includes β-lactam API manufacturers, 6-APA manufacturers, 7-ACA manufacturers, 7-ADCA producers, semi-synthetic penicillin producers, cephalosporin manufacturers, pharmaceutical CDMOs, and antibiotic intermediate producers.

Enzymes for β-lactam antibiotics are a specialized but strategically important segment of pharmaceutical biocatalysis. Their value comes from replacing harsh chemical hydrolysis and side-chain modification routes with selective enzymatic processes that can reduce solvent use, lower waste generation, improve product purity, and support greener antibiotic manufacturing. Penicillin G acylase remains the core commercial enzyme because it is widely used for producing 6-APA, while cephalosporin-related acylases and engineered enzymes are increasingly important for 7-ACA, 7-ADCA and semi-synthetic cephalosporin pathways. Immobilized enzymes dominate many industrial applications because they can be reused, separated more easily, and operated with better stability in continuous or repeated batch processes. Market growth is mainly driven by sustained demand for amoxicillin, ampicillin, cephalexin, cefadroxil and other semi-synthetic β-lactam antibiotics, as well as pressure to improve environmental performance in antibiotic API manufacturing. However, growth is moderate because β-lactam antibiotics are mature products, enzyme costs must remain compatible with low-margin API economics, and some manufacturers already operate highly optimized in-house enzyme systems. Future development will focus on higher enzyme activity, better thermal and pH stability, lower product inhibition, improved immobilization carriers, recombinant enzyme production, direct one-step conversion of cephalosporin C to 7-ACA, and customized biocatalysts for greener semi-synthetic antibiotic routes.

This report delivers a comprehensive overview of the global Enzymes for β-lactam Antibiotics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Enzymes for β-lactam Antibiotics. The Enzymes for β-lactam Antibiotics market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Enzymes for β-lactam Antibiotics market comprehensively. Regional market sizes by Type, by Application, by Process Use, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Enzymes for β-lactam Antibiotics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Novozymes / Novonesis
DSM / dsm-firmenich
Amano Enzyme
Fermenta Biotech
Advanced Enzyme Technologies
Biosynth
Creative Enzymes
Codexis
c-LEcta / Kerry
Meiji Seika Pharma
Kyowa Hakko Bio
Datong Shuangyan Pharmaceutical
Shanghai Enzyme
Hubei Merriclin Pharmaceutical
Zhejiang Huahai Pharmaceutical
North China Pharmaceutical
CSPC Pharmaceutical Group

Segment by Type
β-lactamase
Penicillin Acylase
Other

Segment by Process Use
6-APA Route
7-ACA Route
7-ADCA Route
Semi-Synthetic Antibiotic Route

Segment by Product Form
Free Enzyme Type
Immobilized Enzyme Type
Recombinant Enzyme Type
Whole-Cell Catalyst Type

by Application
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other

Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Process Use, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Enzymes for β-lactam Antibiotics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Enzymes for β-lactam Antibiotics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

Table of Contents

1 Enzymes for β-lactam Antibiotics Market Overview
1.1 Product Definition
1.2 Enzymes for β-lactam Antibiotics by Type
1.2.1 Global Enzymes for β-lactam Antibiotics Market Value by Type: 2025 vs 2032
1.2.2 β-lactamase
1.2.3 Penicillin Acylase
1.2.4 Other
1.3 Enzymes for β-lactam Antibiotics by Process Use
1.3.1 Global Enzymes for β-lactam Antibiotics Market Value by Process Use: 2025 vs 2032
1.3.2 6-APA Route
1.3.3 7-ACA Route
1.3.4 7-ADCA Route
1.3.5 Semi-Synthetic Antibiotic Route
1.4 Enzymes for β-lactam Antibiotics by Product Form
1.4.1 Global Enzymes for β-lactam Antibiotics Market Value by Product Form: 2025 vs 2032
1.4.2 Free Enzyme Type
1.4.3 Immobilized Enzyme Type
1.4.4 Recombinant Enzyme Type
1.4.5 Whole-Cell Catalyst Type
1.5 Enzymes for β-lactam Antibiotics by Application
1.5.1 Global Enzymes for β-lactam Antibiotics Market Value by Application: 2025 vs 2032
1.5.2 Cephalosporins
1.5.3 Penicillin and Its Derivatives
1.5.4 Monoamide Ring
1.5.5 Other
1.6 Global Enzymes for β-lactam Antibiotics Market Size Estimates and Forecasts
1.6.1 Global Enzymes for β-lactam Antibiotics Revenue 2021–2032
1.6.2 Global Enzymes for β-lactam Antibiotics Sales 2021–2032
1.6.3 Global Enzymes for β-lactam Antibiotics Market Average Price (2021–2032)
1.7 Assumptions and Limitations

2 Enzymes for β-lactam Antibiotics Market Competition by Manufacturers
2.1 Global Enzymes for β-lactam Antibiotics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Enzymes for β-lactam Antibiotics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Enzymes for β-lactam Antibiotics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Product Types and Applications
2.7 Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Date of Entry into the Industry
2.8 Global Enzymes for β-lactam Antibiotics Market Competitive Situation and Trends
2.8.1 Global Enzymes for β-lactam Antibiotics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Enzymes for β-lactam Antibiotics Players Market Share by Revenue
2.8.3 Global Enzymes for β-lactam Antibiotics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enzymes for β-lactam Antibiotics Market Scenario by Region
3.1 Global Enzymes for β-lactam Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021–2032
3.2.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021–2026
3.2.2 Global Enzymes for β-lactam Antibiotics Sales by Region: 2027–2032
3.3 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021–2032
3.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021–2026
3.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2027–2032
3.4 North America Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
3.4.1 North America Enzymes for β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Enzymes for β-lactam Antibiotics Sales by Country (2021–2032)
3.4.3 North America Enzymes for β-lactam Antibiotics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
3.5.1 Europe Enzymes for β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Enzymes for β-lactam Antibiotics Sales by Country (2021–2032)
3.5.3 Europe Enzymes for β-lactam Antibiotics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzymes for β-lactam Antibiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Enzymes for β-lactam Antibiotics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Enzymes for β-lactam Antibiotics Sales by Region (2021–2032)
3.6.3 Asia Pacific Enzymes for β-lactam Antibiotics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Enzymes for β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Enzymes for β-lactam Antibiotics Sales by Country (2021–2032)
3.7.3 Latin America Enzymes for β-lactam Antibiotics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Enzymes for β-lactam Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzymes for β-lactam Antibiotics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Enzymes for β-lactam Antibiotics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE

4 Segment by Type
4.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021–2032)
4.1.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021–2026)
4.1.2 Global Enzymes for β-lactam Antibiotics Sales by Type (2027–2032)
4.1.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021–2032)
4.2 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021–2032)
4.2.1 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021–2026)
4.2.2 Global Enzymes for β-lactam Antibiotics Revenue by Type (2027–2032)
4.2.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021–2032)
4.3 Global Enzymes for β-lactam Antibiotics Price by Type (2021–2032)

5 Segment by Application
5.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021–2032)
5.1.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021–2026)
5.1.2 Global Enzymes for β-lactam Antibiotics Sales by Application (2027–2032)
5.1.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021–2032)
5.2 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021–2032)
5.2.1 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021–2026)
5.2.2 Global Enzymes for β-lactam Antibiotics Revenue by Application (2027–2032)
5.2.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021–2032)
5.3 Global Enzymes for β-lactam Antibiotics Price by Application (2021–2032)

6 Key Companies Profiled
6.1 Novozymes / Novonesis
6.1.1 Novozymes / Novonesis Company Information
6.1.2 Novozymes / Novonesis Description and Business Overview
6.1.3 Novozymes / Novonesis Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novozymes / Novonesis Enzymes for β-lactam Antibiotics Product Portfolio
6.1.5 Novozymes / Novonesis Recent Developments/Updates
6.2 DSM / dsm-firmenich
6.2.1 DSM / dsm-firmenich Company Information
6.2.2 DSM / dsm-firmenich Description and Business Overview
6.2.3 DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Product Portfolio
6.2.5 DSM / dsm-firmenich Recent Developments/Updates
6.3 Amano Enzyme
6.3.1 Amano Enzyme Company Information
6.3.2 Amano Enzyme Description and Business Overview
6.3.3 Amano Enzyme Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Amano Enzyme Enzymes for β-lactam Antibiotics Product Portfolio
6.3.5 Amano Enzyme Recent Developments/Updates
6.4 Fermenta Biotech
6.4.1 Fermenta Biotech Company Information
6.4.2 Fermenta Biotech Description and Business Overview
6.4.3 Fermenta Biotech Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Fermenta Biotech Enzymes for β-lactam Antibiotics Product Portfolio
6.4.5 Fermenta Biotech Recent Developments/Updates
6.5 Advanced Enzyme Technologies
6.5.1 Advanced Enzyme Technologies Company Information
6.5.2 Advanced Enzyme Technologies Description and Business Overview
6.5.3 Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Product Portfolio
6.5.5 Advanced Enzyme Technologies Recent Developments/Updates
6.6 Biosynth
6.6.1 Biosynth Company Information
6.6.2 Biosynth Description and Business Overview
6.6.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
6.6.5 Biosynth Recent Developments/Updates
6.7 Creative Enzymes
6.7.1 Creative Enzymes Company Information
6.7.2 Creative Enzymes Description and Business Overview
6.7.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
6.7.5 Creative Enzymes Recent Developments/Updates
6.8 Codexis
6.8.1 Codexis Company Information
6.8.2 Codexis Description and Business Overview
6.8.3 Codexis Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Codexis Enzymes for β-lactam Antibiotics Product Portfolio
6.8.5 Codexis Recent Developments/Updates
6.9 c-LEcta / Kerry
6.9.1 c-LEcta / Kerry Company Information
6.9.2 c-LEcta / Kerry Description and Business Overview
6.9.3 c-LEcta / Kerry Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 c-LEcta / Kerry Enzymes for β-lactam Antibiotics Product Portfolio
6.9.5 c-LEcta / Kerry Recent Developments/Updates
6.10 Meiji Seika Pharma
6.10.1 Meiji Seika Pharma Company Information
6.10.2 Meiji Seika Pharma Description and Business Overview
6.10.3 Meiji Seika Pharma Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Meiji Seika Pharma Enzymes for β-lactam Antibiotics Product Portfolio
6.10.5 Meiji Seika Pharma Recent Developments/Updates
6.11 Kyowa Hakko Bio
6.11.1 Kyowa Hakko Bio Company Information
6.11.2 Kyowa Hakko Bio Description and Business Overview
6.11.3 Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Product Portfolio
6.11.5 Kyowa Hakko Bio Recent Developments/Updates
6.12 Datong Shuangyan Pharmaceutical
6.12.1 Datong Shuangyan Pharmaceutical Company Information
6.12.2 Datong Shuangyan Pharmaceutical Description and Business Overview
6.12.3 Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Product Portfolio
6.12.5 Datong Shuangyan Pharmaceutical Recent Developments/Updates
6.13 Shanghai Enzyme
6.13.1 Shanghai Enzyme Company Information
6.13.2 Shanghai Enzyme Description and Business Overview
6.13.3 Shanghai Enzyme Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Shanghai Enzyme Enzymes for β-lactam Antibiotics Product Portfolio
6.13.5 Shanghai Enzyme Recent Developments/Updates
6.14 Hubei Merriclin Pharmaceutical
6.14.1 Hubei Merriclin Pharmaceutical Company Information
6.14.2 Hubei Merriclin Pharmaceutical Description and Business Overview
6.14.3 Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Product Portfolio
6.14.5 Hubei Merriclin Pharmaceutical Recent Developments/Updates
6.15 Zhejiang Huahai Pharmaceutical
6.15.1 Zhejiang Huahai Pharmaceutical Company Information
6.15.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
6.15.3 Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Product Portfolio
6.15.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
6.16 North China Pharmaceutical
6.16.1 North China Pharmaceutical Company Information
6.16.2 North China Pharmaceutical Description and Business Overview
6.16.3 North China Pharmaceutical Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 North China Pharmaceutical Enzymes for β-lactam Antibiotics Product Portfolio
6.16.5 North China Pharmaceutical Recent Developments/Updates
6.17 CSPC Pharmaceutical Group
6.17.1 CSPC Pharmaceutical Group Company Information
6.17.2 CSPC Pharmaceutical Group Description and Business Overview
6.17.3 CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Product Portfolio
6.17.5 CSPC Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
7.1 Enzymes for β-lactam Antibiotics Industry Chain Analysis
7.2 Enzymes for β-lactam Antibiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzymes for β-lactam Antibiotics Production Mode & Process Analysis
7.4 Enzymes for β-lactam Antibiotics Sales and Marketing
7.4.1 Enzymes for β-lactam Antibiotics Sales Channels
7.4.2 Enzymes for β-lactam Antibiotics Distributors
7.5 Enzymes for β-lactam Antibiotics Customer Analysis

8 Enzymes for β-lactam Antibiotics Market Dynamics
8.1 Enzymes for β-lactam Antibiotics Industry Trends
8.2 Enzymes for β-lactam Antibiotics Market Drivers
8.3 Enzymes for β-lactam Antibiotics Market Challenges
8.4 Enzymes for β-lactam Antibiotics Market Restraints
8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Enzymes for β-lactam Antibiotics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Enzymes for β-lactam Antibiotics Market Value by Process Use (US$ Million), 2025 vs 2032
 Table 3. Global Enzymes for β-lactam Antibiotics Market Value by Product Form (US$ Million), 2025 vs 2032
 Table 4. Global Enzymes for β-lactam Antibiotics Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Enzymes for β-lactam Antibiotics Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Enzymes for β-lactam Antibiotics Sales (Tons) of Key Manufacturers (2021–2026)
 Table 7. Global Enzymes for β-lactam Antibiotics Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Enzymes for β-lactam Antibiotics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Enzymes for β-lactam Antibiotics Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Enzymes for β-lactam Antibiotics Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Enzymes for β-lactam Antibiotics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Product Types and Applications
 Table 14. Global Key Manufacturers of Enzymes for β-lactam Antibiotics, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Enzymes for β-lactam Antibiotics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Enzymes for β-lactam Antibiotics Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Enzymes for β-lactam Antibiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Enzymes for β-lactam Antibiotics Sales by Region (Tons), 2021–2026
 Table 20. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2021–2026)
 Table 21. Global Enzymes for β-lactam Antibiotics Sales by Region (Tons), 2027–2032
 Table 22. Global Enzymes for β-lactam Antibiotics Sales Market Share by Region (2027–2032)
 Table 23. Global Enzymes for β-lactam Antibiotics Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2021–2026)
 Table 25. Global Enzymes for β-lactam Antibiotics Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2027–2032)
 Table 27. North America Enzymes for β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 29. North America Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 30. North America Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Enzymes for β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 34. Europe Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 35. Europe Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Enzymes for β-lactam Antibiotics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Enzymes for β-lactam Antibiotics Sales by Region (Tons), 2021–2026
 Table 39. Asia Pacific Enzymes for β-lactam Antibiotics Sales by Region (Tons), 2027–2032
 Table 40. Asia Pacific Enzymes for β-lactam Antibiotics Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Enzymes for β-lactam Antibiotics Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Enzymes for β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 44. Latin America Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 45. Latin America Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2021–2026
 Table 49. Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (Tons), 2027–2032
 Table 50. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Enzymes for β-lactam Antibiotics Sales (Tons) by Type (2021–2026)
 Table 53. Global Enzymes for β-lactam Antibiotics Sales (Tons) by Type (2027–2032)
 Table 54. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021–2026)
 Table 55. Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2027–2032)
 Table 56. Global Enzymes for β-lactam Antibiotics Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Enzymes for β-lactam Antibiotics Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021–2026)
 Table 59. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2027–2032)
 Table 60. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Type (2021–2026)
 Table 61. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Type (2027–2032)
 Table 62. Global Enzymes for β-lactam Antibiotics Sales (Tons) by Application (2021–2026)
 Table 63. Global Enzymes for β-lactam Antibiotics Sales (Tons) by Application (2027–2032)
 Table 64. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021–2026)
 Table 65. Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2027–2032)
 Table 66. Global Enzymes for β-lactam Antibiotics Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Enzymes for β-lactam Antibiotics Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021–2026)
 Table 69. Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2027–2032)
 Table 70. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Application (2021–2026)
 Table 71. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Application (2027–2032)
 Table 72. Novozymes / Novonesis Company Information
 Table 73. Novozymes / Novonesis Description and Business Overview
 Table 74. Novozymes / Novonesis Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 75. Novozymes / Novonesis Enzymes for β-lactam Antibiotics Product
 Table 76. Novozymes / Novonesis Recent Developments/Updates
 Table 77. DSM / dsm-firmenich Company Information
 Table 78. DSM / dsm-firmenich Description and Business Overview
 Table 79. DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 80. DSM / dsm-firmenich Enzymes for β-lactam Antibiotics Product
 Table 81. DSM / dsm-firmenich Recent Developments/Updates
 Table 82. Amano Enzyme Company Information
 Table 83. Amano Enzyme Description and Business Overview
 Table 84. Amano Enzyme Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 85. Amano Enzyme Enzymes for β-lactam Antibiotics Product
 Table 86. Amano Enzyme Recent Developments/Updates
 Table 87. Fermenta Biotech Company Information
 Table 88. Fermenta Biotech Description and Business Overview
 Table 89. Fermenta Biotech Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 90. Fermenta Biotech Enzymes for β-lactam Antibiotics Product
 Table 91. Fermenta Biotech Recent Developments/Updates
 Table 92. Advanced Enzyme Technologies Company Information
 Table 93. Advanced Enzyme Technologies Description and Business Overview
 Table 94. Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 95. Advanced Enzyme Technologies Enzymes for β-lactam Antibiotics Product
 Table 96. Advanced Enzyme Technologies Recent Developments/Updates
 Table 97. Biosynth Company Information
 Table 98. Biosynth Description and Business Overview
 Table 99. Biosynth Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 100. Biosynth Enzymes for β-lactam Antibiotics Product
 Table 101. Biosynth Recent Developments/Updates
 Table 102. Creative Enzymes Company Information
 Table 103. Creative Enzymes Description and Business Overview
 Table 104. Creative Enzymes Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 105. Creative Enzymes Enzymes for β-lactam Antibiotics Product
 Table 106. Creative Enzymes Recent Developments/Updates
 Table 107. Codexis Company Information
 Table 108. Codexis Description and Business Overview
 Table 109. Codexis Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 110. Codexis Enzymes for β-lactam Antibiotics Product
 Table 111. Codexis Recent Developments/Updates
 Table 112. c-LEcta / Kerry Company Information
 Table 113. c-LEcta / Kerry Description and Business Overview
 Table 114. c-LEcta / Kerry Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 115. c-LEcta / Kerry Enzymes for β-lactam Antibiotics Product
 Table 116. c-LEcta / Kerry Recent Developments/Updates
 Table 117. Meiji Seika Pharma Company Information
 Table 118. Meiji Seika Pharma Description and Business Overview
 Table 119. Meiji Seika Pharma Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 120. Meiji Seika Pharma Enzymes for β-lactam Antibiotics Product
 Table 121. Meiji Seika Pharma Recent Developments/Updates
 Table 122. Kyowa Hakko Bio Company Information
 Table 123. Kyowa Hakko Bio Description and Business Overview
 Table 124. Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 125. Kyowa Hakko Bio Enzymes for β-lactam Antibiotics Product
 Table 126. Kyowa Hakko Bio Recent Developments/Updates
 Table 127. Datong Shuangyan Pharmaceutical Company Information
 Table 128. Datong Shuangyan Pharmaceutical Description and Business Overview
 Table 129. Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 130. Datong Shuangyan Pharmaceutical Enzymes for β-lactam Antibiotics Product
 Table 131. Datong Shuangyan Pharmaceutical Recent Developments/Updates
 Table 132. Shanghai Enzyme Company Information
 Table 133. Shanghai Enzyme Description and Business Overview
 Table 134. Shanghai Enzyme Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 135. Shanghai Enzyme Enzymes for β-lactam Antibiotics Product
 Table 136. Shanghai Enzyme Recent Developments/Updates
 Table 137. Hubei Merriclin Pharmaceutical Company Information
 Table 138. Hubei Merriclin Pharmaceutical Description and Business Overview
 Table 139. Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 140. Hubei Merriclin Pharmaceutical Enzymes for β-lactam Antibiotics Product
 Table 141. Hubei Merriclin Pharmaceutical Recent Developments/Updates
 Table 142. Zhejiang Huahai Pharmaceutical Company Information
 Table 143. Zhejiang Huahai Pharmaceutical Description and Business Overview
 Table 144. Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 145. Zhejiang Huahai Pharmaceutical Enzymes for β-lactam Antibiotics Product
 Table 146. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
 Table 147. North China Pharmaceutical Company Information
 Table 148. North China Pharmaceutical Description and Business Overview
 Table 149. North China Pharmaceutical Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 150. North China Pharmaceutical Enzymes for β-lactam Antibiotics Product
 Table 151. North China Pharmaceutical Recent Developments/Updates
 Table 152. CSPC Pharmaceutical Group Company Information
 Table 153. CSPC Pharmaceutical Group Description and Business Overview
 Table 154. CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Sales (Tons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 155. CSPC Pharmaceutical Group Enzymes for β-lactam Antibiotics Product
 Table 156. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. Enzymes for β-lactam Antibiotics Distributors List
 Table 160. Enzymes for β-lactam Antibiotics Customers List
 Table 161. Enzymes for β-lactam Antibiotics Market Trends
 Table 162. Enzymes for β-lactam Antibiotics Market Drivers
 Table 163. Enzymes for β-lactam Antibiotics Market Challenges
 Table 164. Enzymes for β-lactam Antibiotics Market Restraints
 Table 165. Research Programs/Design for This Report
 Table 166. Key Data Information from Secondary Sources
 Table 167. Key Data Information from Primary Sources
 Table 168. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Enzymes for β-lactam Antibiotics
 Figure 2. Global Enzymes for β-lactam Antibiotics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Enzymes for β-lactam Antibiotics Market Share by Type: 2025 & 2032
 Figure 4. β-lactamase Product Picture
 Figure 5. Penicillin Acylase Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Enzymes for β-lactam Antibiotics Market Value by Process Use (US$ Million), 2021–2032
 Figure 8. Global Enzymes for β-lactam Antibiotics Market Share by Process Use: 2025 vs 2032
 Figure 9. 6-APA Route Product Picture
 Figure 10. 7-ACA Route Product Picture
 Figure 11. 7-ADCA Route Product Picture
 Figure 12. Semi-Synthetic Antibiotic Route Product Picture
 Figure 13. Global Enzymes for β-lactam Antibiotics Market Value by Product Form (US$ Million), 2021–2032
 Figure 14. Global Enzymes for β-lactam Antibiotics Market Share by Product Form: 2025 vs 2032
 Figure 15. Free Enzyme Type Product Picture
 Figure 16. Immobilized Enzyme Type Product Picture
 Figure 17. Recombinant Enzyme Type Product Picture
 Figure 18. Whole-Cell Catalyst Type Product Picture
 Figure 19. Global Enzymes for β-lactam Antibiotics Market Value by Application (US$ Million), 2021–2032
 Figure 20. Global Enzymes for β-lactam Antibiotics Market Share by Application: 2025 & 2032
 Figure 21. Cephalosporins
 Figure 22. Penicillin and Its Derivatives
 Figure 23. Monoamide Ring
 Figure 24. Other
 Figure 25. Global Enzymes for β-lactam Antibiotics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 26. Global Enzymes for β-lactam Antibiotics Market Size (US$ Million), 2021–2032
 Figure 27. Global Enzymes for β-lactam Antibiotics Sales (Tons), 2021–2032
 Figure 28. Global Enzymes for β-lactam Antibiotics Average Price (US$/Ton), 2021–2032
 Figure 29. Enzymes for β-lactam Antibiotics Report Years Considered
 Figure 30. Enzymes for β-lactam Antibiotics Sales Share by Manufacturers in 2025
 Figure 31. Global Enzymes for β-lactam Antibiotics Revenue Share by Manufacturers in 2025
 Figure 32. Top 5 and Top 10 Global Enzymes for β-lactam Antibiotics Players: Market Share by Revenue in Enzymes for β-lactam Antibiotics in 2025
 Figure 33. Enzymes for β-lactam Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 34. Global Enzymes for β-lactam Antibiotics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 35. North America Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 36. North America Enzymes for β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 37. United States Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Canada Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Europe Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 40. Europe Enzymes for β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 41. Germany Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. France Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. U.K. Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Italy Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Russia Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Asia Pacific Enzymes for β-lactam Antibiotics Sales Market Share by Region (2021–2032)
 Figure 47. Asia Pacific Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2021–2032)
 Figure 48. China Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Japan Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. South Korea Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. India Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Australia Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. China Taiwan Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Southeast Asia Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Latin America Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 56. Latin America Enzymes for β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 57. Mexico Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Brazil Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Argentina Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Colombia Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Middle East and Africa Enzymes for β-lactam Antibiotics Sales Market Share by Country (2021–2032)
 Figure 62. Middle East and Africa Enzymes for β-lactam Antibiotics Revenue Market Share by Country (2021–2032)
 Figure 63. Turkey Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 64. Saudi Arabia Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 65. UAE Enzymes for β-lactam Antibiotics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 66. Global Sales Market Share of Enzymes for β-lactam Antibiotics by Type (2021–2032)
 Figure 67. Global Revenue Market Share of Enzymes for β-lactam Antibiotics by Type (2021–2032)
 Figure 68. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Type (2021–2032)
 Figure 69. Global Sales Market Share of Enzymes for β-lactam Antibiotics by Application (2021–2032)
 Figure 70. Global Revenue Market Share of Enzymes for β-lactam Antibiotics by Application (2021–2032)
 Figure 71. Global Enzymes for β-lactam Antibiotics Price (US$/Ton) by Application (2021–2032)
 Figure 72. Enzymes for β-lactam Antibiotics Value Chain
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed

以下、関連資料のご紹介